Sun Pharmaceutical Industries, the drug company, on 4 June 2013 announced that got the final approval from US health regulator, US Food and Drug Administration (USFDA) for generic testosterone cypionate injection used for the treatment of testosterone hormone deficiency.
Sun Pharmaceutical Industries got final approval from USFDA for abbreviated new drug application (ANDA) for generic version of Depo-Testosterone Injection, Testosterone Cypionate Injection USP. The approval was given for the injection in 100 mg/ml and 200mg/ml strengths.
The generic testosterone cypionate injection of Sun Pharma is rapeutically equivalent to the Depo Testosterone injection of Pfizer Inc.
This injection is used for the purpose of replacement therapy in males under those conditions which are associated with the symptoms of deficiency or lack of endogenous testosterone.